Russell Investments Group Ltd. Acquires 114,119 Shares of Lifevantage Corporation $LFVN

Key Points

• Russell Investments Group Ltd. significantly increased its stake in Lifevantage Corporation, raising its position by 393,513.8% to own approximately 114,148 shares valued at $1.66 million.
• Insider trading activity was noted as CFO Carl Aure sold 2,746 shares, decreasing his ownership by 2.02%, while insiders hold 20.65% of the stock.
• Lifevantage's stock opened at $12.93, with a 12-month trading range between $7.09 and $27.38, and the company has a market cap of $162.79 million.

Russell Investments Group Ltd. increased its position in shares of Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 393,513.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,148 shares of the company's stock after purchasing an additional 114,119 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.91% of Lifevantage worth $1,664,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Brown Advisory Inc. acquired a new stake in shares of Lifevantage during the first quarter worth approximately $150,000. Cannon Global Investment Management LLC acquired a new stake in Lifevantage during the 1st quarter valued at $156,000. XTX Topco Ltd bought a new position in Lifevantage in the 1st quarter valued at $186,000. Cambridge Investment Research Advisors Inc. boosted its stake in Lifevantage by 23.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock worth $188,000 after purchasing an additional 2,421 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC bought a new stake in shares of Lifevantage during the fourth quarter worth $282,000. 35.32% of the stock is owned by institutional investors.

Lifevantage Price Performance

Shares of Lifevantage stock remained flat at $13.10 during trading on Monday. The company had a trading volume of 139,266 shares, compared to its average volume of 92,654. The stock has a 50 day moving average of $13.09 and a 200-day moving average of $13.76. The firm has a market capitalization of $164.93 million, a PE ratio of 18.99 and a beta of 0.39. Lifevantage Corporation has a fifty-two week low of $7.09 and a fifty-two week high of $27.38.

Lifevantage Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Monday, September 8th will be given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Monday, September 8th. Lifevantage's dividend payout ratio is presently 26.09%.

Insider Activity at Lifevantage

In other news, CFO Carl Aure sold 2,746 shares of the stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total transaction of $36,768.94. Following the sale, the chief financial officer directly owned 133,303 shares of the company's stock, valued at $1,784,927.17. This represents a 2.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 20.65% of the stock is owned by company insiders.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.